A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
CNBC • U.S. • 1 hour ago
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
Related News
New York Times reporters are subpoenaed after Air Force One reporting, newspaper says
The New York Times reports the Trump administration has subpoenaed several of its journalists after their report over s…
These are America’s 10 worst states to live in for 2026
Some states may have low costs and light regulation, but high crime and lack of healthcare are among important factors …
CNBC
• 34 minutes ago
The best states to live in for 2026: No. 1 has a six-year winning streak
Return to office mandates and a decline in remote work have companies looking more closely at the quality of life in th…
CNBC
• 34 minutes ago
Burnout, frustration and heartbreak: Amazon layoffs take their toll in saturated job market
In the eight-plus months since Amazon announced its most expansive job cuts ever, laid off workers have been thrust int…
CNBC
• 1 hour ago
As gas plants rise to power AI, renewable energy allies are fighting for cleaner alternatives
Renewable energy allies are trying to ensure that massive data centers will be powered by climate-friendly sources
An American Politician is Blocked by Israeli Settlers in the West Bank
Representative Ro Khanna was barred from leaving for 90 minutes. Where past U.S. leaders toured the region to show supp…